by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersSaNOtize

All Warning Letters

SaNOtize

Warning LetterOpen

1-8755 Ash Street Vancouver BC V6P 6T3 CanadaIssued Apr 17, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateApr 17, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: SaNOtize
Location: 1-8755 Ash Street Vancouver BC V6P 6T3 Canada
FEI Number: N/A
Country: Canada
Issue Date: April 17, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Unapproved New Drugs

SaNOtize FDA Warning Letter, April 17, 2026